Secondary outcome: Improvement of disease activity (skin softening) · children and adults with active morphea (circumscribed morphea, linear scleroderma (with trunk/limb variant and head variant), generalised…
1 finding from 1 review
Secondary outcome: Improvement of disease damage ‐ not measured · children and adults with active morphea (circumscribed morphea, linear scleroderma (with trunk/limb variant and head variant), generalised…
The review found no eligible studies for this question.
1 finding from 1 review
Abstinence · people who smoke
It is very uncertain whether smartphone app changes long‐term abstinence (all randomised) compared with lower‐intensity support (very low certainty).
1 finding from 1 review
Intervention not reported
Smoking cessation at ≥ 6 months · tobacco smokers (general population, low income, inpatients and outpatients with mixed diagnoses)
The intervention showed no clear difference in smoking cessation at ≥ 6 months (low certainty).
1 finding from 1 review
Smoking cessation · tobacco smokers (general population, hospital inpatients with mixed diagnoses)
Higher may leads to higher smoking cessation at ≥ 6 months compared with lower intensity motivational interviewing (low certainty).
1 finding from 1 review
Intervention not reported
Enrolment · adults (age 18 years or over) with myocardial infarction, stable angina, following coronary artery bypass graft surgery or percutaneous…
The intervention may leads to higher enrolment (low certainty).
1 finding from 1 review
Intervention not reported
Adherence · adults (age 18 years or over) with myocardial infarction, stable angina, following coronary artery bypass graft surgery or percutaneous…
1 finding from 1 review
Intervention not reported
Completion · adults (age 18 years or over) with myocardial infarction, stable angina, following coronary artery bypass graft surgery or percutaneous…
The intervention probably leads to higher completion (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events · adults (age 18 years or over) with myocardial infarction, stable angina, following coronary artery bypass graft surgery or percutaneous…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women requiring a repeat regional block or a general anaesthetic as a result of failure to establish adequate initial blockade · women undergoing caesarean section
Combined spinal‐epidural showed no clear difference in number of women requiring a repeat regional block or a general… compared with low‐dose spinal (low certainty).
1 finding from 1 review
Number of women requiring supplemental intra‐operative analgesia at any time after CSE or spinal anaesthetic insertion · women undergoing caesarean section
Combined spinal‐epidural showed no clear difference in number of women requiring supplemental intra‐operative analgesia at… compared with low‐dose spinal (moderate certainty).
1 finding from 1 review
Number of women requiring intra‐operative conversion to general anaesthesia · women undergoing caesarean section
1 finding from 1 review
Number of women satisfied with anaesthesia · women undergoing caesarean section
1 finding from 1 review
Clinical relapse · people with surgically‐induced remission in Crohn's disease
High dose 5‐ASA showed no clear difference in clinical relapse compared with low dose 5‐ASA (moderate certainty).
1 finding from 1 review
Endoscopic recurrence · people with surgically‐induced remission in Crohn's disease
High dose 5‐ASA showed no clear difference in endoscopic recurrence compared with low dose 5‐ASA (moderate certainty).
1 finding from 1 review
Radiologic relapse · people with surgically‐induced remission in Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with surgically‐induced remission in Crohn's disease
High dose 5‐ASA showed no clear difference in adverse events compared with low dose 5‐ASA (low certainty).
1 finding from 1 review
Serious adverse events · people with surgically‐induced remission in Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · people with surgically‐induced remission in Crohn's disease
High dose 5‐ASA showed no clear difference in withdrawal due to adverse events compared with low dose 5‐ASA (low certainty).
1 finding from 1 review
Health related quality of life · people with surgically‐induced remission in Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found